Pharmaceutical Preparations · DE · CIK 1069530
Develops transformative medicines for CNS disorders by modulating filamin A, with simufilam for TSC-related epilepsy
Comparable business profile · signals at a glance
In the 90 days to Nov 24, 2025: 3 insiders bought $681K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 24, 2025 | Anderson Robert Eugene JrDirector | Buy | 8,600 | $2.90 | $25K |
| Nov 20, 2025 | Barry RichardPresident & CEO | Buy | 150,000 | $2.76 | $414K |
| Nov 19, 2025 | Barry RichardPresident & CEO | Buy | 73,385 | $2.75 | $202K |
| Sep 30, 2025 | Cook Robert ChristopherChief Operating & Legal Office | Buy | 13,725 | $2.91 | $40K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.